BIO-PATH HOLDINGS
Bio-Path is a biotechnology company developing DNAbilize®, a novel technology that has yielded a pipeline of RNAi nanoparticle drugs that can be administered with a simple intravenous infusion. Bio-Path’s lead product candidate, prexigebersen (BP1001, targeting the Grb2 protein), is in a Phase 2 study for blood cancers and prexigebersen-A, a drug product modification of prexigebersen, is under consideration by the FDA to commence Phase 1 studies in solid tumors.
BIO-PATH HOLDINGS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2007-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.biopathholdings.com
Total Employee:
1+
Status:
Active
Contact:
(832)971-6616
Total Funding:
46.12 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
1200 Pharma
1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Signpath Pharma
Signpath Pharma is a biotechnology company developing therapeutics using curcuminoids extracted from the root of the Curcuma longa plant.
Sonnet BioTherapeutics
Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action.
Current Advisors List
Board_member
Current Employees Featured
Ana Tari Ashizawa Co-Founder , SVP of Research, Development & Clinical Design @ Bio-Path Holdings
Co-Founder , SVP of Research, Development & Clinical Design
2019-07-01
Douglas P. Morris Co-Founder & Director of Investor Relations @ Bio-Path Holdings
Co-Founder & Director of Investor Relations
Peter Nielsen Co-Founder ,CEO & CFO @ Bio-Path Holdings
Co-Founder ,CEO & CFO
Founder
Stock Details
Official Site Inspections
http://www.biopathholdings.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
